Michael Happich has extensive experience in health economics and research within the pharmaceutical industry. Starting as a Research Scientist at GSF from November 2002 to June 2005, Michael transitioned to Lilly Deutschland GmbH as a PRA Manager until September 2008. Following this, Michael held various positions at Eli Lilly and Company including Research Scientist, Senior Research Scientist, Director of Global Patient Outcomes and Real World Evidence, and Sr Director HTA for International Markets, leading teams to develop evidence for successful Health Technology Assessments globally. Michael holds a Master's Degree in Economics and a Ph.D. in Health Economics from Humboldt-Universität zu Berlin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices